← All trials
NCT02072798
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2014
- Primary completion
- Jul 1, 2014
- Completion date
- Aug 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 42
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of Southern DenmarkLead sponsor
- University of Southern DenmarkReponsible party - principal investigator
- University of Southern DenmarkStudy chair
- University of CopenhagenCollaborator
- University of Southern DenmarkCollaborator
- Aase and Ejnar Danielsens FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.